Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > C. Roy Hardiman > Profile

C. Roy Hardiman

Affiliations

  • Chief Business & Strategy Ofcr at Alumis Inc. (ALMS), 2025-02-21
  • Chief Business Officer at Principia Biopharma Inc. (PRNB), 2020-09-28
  • Director at Pharmacyclics Inc (PCYC), 2012-10-03
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRNB $99.98 5,000 $499,917.50 117,761 2020-09-18 Filing
PRNB $62.13 863 $53,617.24 117,761 2020-06-12 Filing
PRNB $61.62 2,542 $156,630.16 118,624 2020-06-12 Filing
PRNB $59.90 1,595 $95,540.98 121,166 2020-06-12 Filing
PRNB $51.04 100 $5,104.00 116,903 2020-03-13 Filing